Daniela Richter

Heidelberg, BW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications

Clinically actionable genomic and transcriptomic landscape of advanced neuroendocrine neoplasms.

Clinically actionable genomic and transcriptomic landscape of advanced neuroendocrine neoplasms.

Journal: Med (New York, N.Y.)
Published: July 27, 2025

Long-read genome and RNA sequencing resolve a pathogenic intronic germline LINE-1 insertion in APC.

Long-read genome and RNA sequencing resolve a pathogenic intronic germline LINE-1 insertion in APC.

Journal: NPJ genomic medicine
Published: September 17, 2024

Genomic landscape and molecularly informed therapy in thymic carcinoma and other advanced thymic epithelial tumors.

Genomic landscape and molecularly informed therapy in thymic carcinoma and other advanced thymic epithelial tumors.

Journal: Med (New York, N.Y.)
Published: September 04, 2024

Translational and clinical comparison of whole genome and transcriptome to panel sequencing in precision oncology.

Translational and clinical comparison of whole genome and transcriptome to panel sequencing in precision oncology.

Journal: NPJ precision oncology
Published: July 24, 2024

Exceptional Response of BRAFV600E-Mutated Acinar Cell CUP to BRAF/MEK Inhibition.

Exceptional Response of BRAFV600E-Mutated Acinar Cell CUP to BRAF/MEK Inhibition.

Journal: JCO precision oncology
Published: May 31, 2024

Signaling-induced systematic repression of miRNAs uncovers cancer vulnerabilities and targeted therapy sensitivity.

Signaling-induced systematic repression of miRNAs uncovers cancer vulnerabilities and targeted therapy sensitivity.

Journal: Cell reports. Medicine
Published: December 19, 2022

Recurrent Germline Variant in RAD21 Predisposes Children to Lymphoblastic Leukemia or Lymphoma.

Recurrent Germline Variant in RAD21 Predisposes Children to Lymphoblastic Leukemia or Lymphoma.

Journal: International journal of molecular sciences
Published: April 12, 2022

Gene expression-based prediction of pazopanib efficacy in sarcoma.

Gene expression-based prediction of pazopanib efficacy in sarcoma.

Journal: European journal of cancer (Oxford, England : 1990)
Published: February 04, 2022

Publisher Correction: Comprehensive genomic characterization of gene therapy-induced T-cell acute lymphoblastic leukemia.

Publisher Correction: Comprehensive genomic characterization of gene therapy-induced T-cell acute lymphoblastic leukemia.

Journal: Leukemia
Published: November 17, 2021

Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly-informed therapies despite heterogeneity.

Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly-informed therapies despite heterogeneity.

Journal: Nature communications
Published: March 05, 2021

Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers.

Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers.

Journal: Cancer discovery
Published: January 29, 2021

Response to Cabozantinib Following Acquired Entrectinib Resistance in a Patient With ETV6-NTRK3 Fusion-Positive Carcinoma Harboring the NTRK3 G623R Solvent-Front Mutation.

Response to Cabozantinib Following Acquired Entrectinib Resistance in a Patient With ETV6-NTRK3 Fusion-Positive Carcinoma Harboring the NTRK3 G623R Solvent-Front Mutation.

Journal: JCO precision oncology
Published: July 15, 2020
Showing 1-12 of 32

Last Updated: 09/26/2026